Objective To systematically review the proportions of infants with early exposure to antenatal
corticosteroids but born at term or late preterm, and short term and long term outcomes …

Respiratory distress syndrome (RDS) care pathways evolve slowly as new evidence
emerges. We report the sixth version of “European Guidelines for the Management of RDS” …

Objective To update recommendations for administration of antenatal corticosteroids in the
late preterm period. Target Population Pregnant individuals at risk of preterm birth from 34 0 …

Background Antenatal corticosteroids have been used for the prevention of respiratory
complications, intraventricular hemorrhage, necrotizing enterocolitis, and other adverse …

Antenatal steroid therapy is increasingly central to the obstetrical management of women at
imminent risk of preterm birth. For women likely to deliver between 24 and 34 weeks' …

The efficacy of antenatal corticosteroids to improve preterm newborn outcomes in low-resource
countries: Are we there yet? The efficacy of antenatal corticosteroids to improve preterm …

Background Preterm birth complications are the leading cause of newborn and under-5
mortality. Over 85% of all preterm births occur in the late preterm period, ie between 34 and< …

The present dosage of Dexamethasone (DEX) administered to pregnant women may pose a
risk of toxicity to their unborn offspring. We aimed to develop a maternal-fetal physiologically …

Dexamethasone (DEX) was applied in neonatal respiratory distress syndrome treatment of
pregnant women. We established a pharmacokinetics (PK)/pharmacodynamics (PD)/end …

Background Antenatal betamethasone is recommended before preterm delivery to
accelerate fetal lung maturation. However, its optimal dose remains unknown. A 50% dose …